Recently, Irving et al reported a panel of methylation markers (CD38, HOXA4, BTG4) in which an overall methylation score was significantly associated with time to first treatment in CLL [25]. This evidence concerns the gene BTG4 and B-cell chronic lymphocytic leukemia.